THE LIMITED ROLE OF CORTICOSTEROIDS IN AMELIORATING EXPERIMENTAL DOXORUBICIN SKIN TOXICITY IN THE MOUSE

被引：44

作者：

DORR, RT ^{[1
]}

ALBERTS, DS ^{[1
]}

CHEN, HSG ^{[1
]}

机构：

[1] UNIV ARIZONA,DEPT INTERNAL MED,DIV CANC CTR,TUCSON,AZ 85724

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1980年 / 5卷 / 01期

关键词：

D O I：

10.1007/BF00578557

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：17 / 20

页数：4

共 17 条

[1]

BACHUR NR, 1975, CANCER CHEMOTH REP 3, V6, P153

[2] NURSING MANAGEMENT OF ADRIAMYCIN EXTRAVASATION [J].

BARLOCK, AL ;

HOWSER, DM ;

HUBBARD, SM .

AMERICAN JOURNAL OF NURSING, 1979, 79 (01) :94-96

[3] ADRIAMYCIN EXTRAVASATION [J].

BOWERS, DG ;

LYNCH, JB .

PLASTIC AND RECONSTRUCTIVE SURGERY, 1978, 61 (01) :86-92

[4]

BRISTOW MR, 1979, P AM ASSOC CANC RES, V20, P118

[5] CUTANEOUS SIDE EFFECTS OF ACTH, CORTISONE AND PREGNENOLONE THERAPY [J].

BRUNNER, MJ ;

RIDDELL, JM ;

BEST, WR .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1951, 16 (04) :205-210

[6]

COHEN MH, 1979, CANCER TREAT REP, V63, P1003

[7] INTERACTION OF SOME DAUNOMYCIN DERIVATIVES WITH DEOXYRIBONUCLEIC ACID AND THEIR BIOLOGICAL ACTIVITY [J].

DIMARCO, A ;

ZUNINO, F ;

SILVESTR.R ;

GAMBARUCCI, C ;

GAMBETTA, RA .

BIOCHEMICAL PHARMACOLOGY, 1971, 20 (06) :1323-+

[8]

DORR RT, 1980, J PHARMACOL METHOD, V4, P321

[9]

FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219

[10]

MYERS CE, 1976, CANCER TREAT REP, V60, P961

← 1 2 →